Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.47 |
| ▸ | PTPN5 | P54829 | 4/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 1/20 | 0.37 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2916477 | 1.00 | CA2 (0.53) | CA2GABRA1GABRB2PTPN5PTPN2 | |
| SCHEMBL10613016 | 0.98 | CA2 (0.55) | CA2GABRA1GABRB2PTPN5PTPN2 | |
| SCHEMBL9654291 | 0.90 | PTPN5 (0.41) | CA2GABRA1GABRB2PTPN5PTPN2 | |
| SCHEMBL16335849 | 0.82 | HTR2C (0.44) | CA2PTPN5PTPN2LMNAALDH1A1 | |
| SCHEMBL4958862 | 0.81 | PTPN5 (0.46) | PTPN5PTPN2FEN1PTGDR2HTR1A | |
| SCHEMBL4958978 | 0.81 | PTPN5 (0.46) | PTPN5PTPN2FEN1PTGDR2HTR1A | |
| SCHEMBL4959318 | 0.81 | PTPN5 (0.46) | PTPN5PTPN2FEN1PTGDR2HTR1A | |
| SCHEMBL4960398 | 0.81 | PTPN5 (0.46) | PTPN5PTPN2FEN1PTGDR2HTR1A | |
| SCHEMBL201425 | 0.81 | PTPN5 (0.46) | PTPN5PTPN2FEN1PTGDR2HTR1A | |
| SCHEMBL9861616 | 0.81 | GAA (0.49) | PTPN5PTPN2TDP1FEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5292970-A | Alkylation | HUELS AKTIENGESELLSCHAFT (DE) | 1994-03-08 | — | — | US | claimed |
| EP-0544074-A1 | Process for the preparation of ortho substituted alkylphenols and catalyst therefor | HÜLS AKTIENGESELLSCHAFT (DE) | 1993-06-02 | — | — | EP | claimed |
| US-8766016-B2 | Green and atom-economical processes for producing phenolic antioxidants | ALBERMARLE CORPORATION (US) | 2014-07-01 | — | — | US | disclosed |
| US-20120108854-A1 | GREEN AND ATOM-ECONOMICAL PROCESSES FOR PRODUCING PHENOLIC ANTIOXIDANTS | ALBEMARLE CORPORATION (US) | 2012-05-03 | — | — | US | disclosed |
| WO-2011005735-A1 | GREEN AND ATOM-ECONOMICAL PROCESSES FOR PRODUCING PHENOLIC ANTIOXIDANTS | ALBEMARLE CORPORATION (US) | 2011-01-13 | — | — | WO | disclosed |
| US-5292970-A | Alkylation | HUELS AKTIENGESELLSCHAFT (DE) | 1994-03-08 | — | — | US | disclosed |
| EP-0544074-A1 | Process for the preparation of ortho substituted alkylphenols and catalyst therefor | HÜLS AKTIENGESELLSCHAFT (DE) | 1993-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108854-A1 | GREEN AND ATOM-ECONOMICAL PROCESSES FOR PRODUCING PHENOLIC ANTIOXIDANTS | TYR, TXN2, TFEB | CA2 1731/4885GABRA1 3041/4885GABRB2 2131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.